Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains

被引:1
|
作者
Li-Hui Wang
机构
关键词
Helicobacter pylori; Antibiotic resistance; Quinolones; Mutation; gyrA;
D O I
暂无
中图分类号
R378 [病原细菌];
学科分类号
100103 ; 100705 ;
摘要
AIM:To investigate the resistance of Helicobacter pylori(H.pylori) to ciprofloxacin(CIP),levofloxacin(LVX) and moxifloxacin(MOX) in the Beijing area and to elucidate the resistance mechanisms.METHODS:Seventy-nine H.pylori clinical strains,isolated from patients who had undergone upper gastrointestinal endoscopy in Peking University First Hospital from 2007 to 2009,were tested for their susceptibility to CIP,LVX and MOX using the E-test method.H.pylori strain 26695 was included in the susceptibility testing as a control strain.According to the minimal inhibitory concentration(MIC) values,a strain was classified as resistant to CIP,LVX or MOX when the MIC was > 1 μg/mL.We amplified by polymerase chain reaction(PCR) and sequenced the quinolone resistance-determining regions of the gyrA and gyrB genes from 29 quinolone-resistant and 16 quinolone-susceptible H.pylori strains selected at random.RESULTS:In this study,the resistance rates of H.pylori to CIP,LVX or MOX were 55.7%(44/79),and the primary resistance rates were 26.6%(21/79).Patients with secondary resistance had received LVX in previous eradication treatments,but not MOX or CIP.Forty-five strains,including 29 CIP,LVX or MOX-resistant strains(MIC:1.5-32 μg/mL) and 16 susceptible strains,were selected randomly from the 79 strains and used in PCR analysis.Among these 45 strains,27 resistant strains had mutations in the gyrA gene,including 11 strains with mutations corresponding to Asp-91(MIC:2-32 μg/mL),one of which also had a mutation corresponding to Val-150,and 16 strains had mutations at Asn-87(MIC:4-32 μg/mL),three of which also had mutations corresponding to Arg-140 or Val-150.In addition,Arg-140,Val-150 or Ala-97 mutations were separately detected in three susceptible strains.Analysis of the gyrB gene showed that one strain of low resistance had a mutation corresponding to Ser-457 that coexisted with an Asp-91 mutation.There was a significant difference in the occurrence of mutations in the gyrA gene between CIP,LVX and MOX-resistant and-susceptible strains(P < 0.05),but 2 resistant strains were found to possess no quinolone resistance-determining region mutations.CONCLUSION:Resistance is primarily mediated through point mutations in gyrA.Whether other mechanisms are responsible for resistance in strains without mutations in the QRDR should be detected.
引用
收藏
页码:2272 / 2277
页数:6
相关论文
共 50 条
  • [31] Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains
    Piana, A
    Are, BM
    Maida, I
    Dore, MP
    Sotgiu, G
    Realdi, G
    Mura, I
    MICROBIOLOGICA, 2002, 25 (02): : 123 - 130
  • [32] Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan
    Kikuchi, Mina
    Ito, Shin
    Yasuda, Mitsuru
    Tsuchiya, Tomohiro
    Hatazaki, Kyoko
    Takanashi, Masaki
    Ezaki, Takayuki
    Deguchi, Takashi
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2376 - 2382
  • [33] Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain
    Rivera, A
    Rebollo, M
    Sánchez, F
    Navarro, F
    Miró, E
    Mirelis, B
    Coll, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (09) : 759 - 761
  • [34] Point Mutations in Furazolidone and Rifampicin Resistance Genes in Helicobacter pylori Strains from Colombia
    Guzman, Kevin Andres
    Hidalgo, Arsenio
    Pazos, Alvaro Jairo
    ANTIBIOTICS-BASEL, 2024, 13 (07):
  • [35] Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro
    Garcia Lazaro, Francisco
    Elisa Rodriguez-Tarazona, R.
    Angel Garcia-Rodrigueza, Jose
    Luis Munoz-Bellido, Juan
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (03) : 252 - 254
  • [36] Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori
    Fiorini, Giulia
    Zullo, Angelo
    Vakil, Nimish
    Saracino, Ilaria M.
    Ricci, Chiara
    Castelli, Valentina
    Gatta, Luigi
    Vaira, Dino
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (02) : 137 - 140
  • [37] Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA
    Trespalacios, Alba A.
    Rimbara, Emiko
    Otero, William
    Reddy, Rita
    Graham, David Y.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 81 (04) : 251 - 255
  • [38] A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
    Maruri, Fernanda
    Sterling, Timothy R.
    Kaiga, Anne W.
    Blackman, Amondrea
    van der Heijden, Yuri F.
    Mayer, Claudine
    Cambau, Emmanuelle
    Aubry, Alexandra
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 819 - 831
  • [39] Metronidazole-resistant Helicobacter pylori isolates without rdxA mutations obtained from Iranian dyspeptic patients
    Rezaei, Sh.
    Abadi, A. Talebi Bezmin
    Mobarez, A. Mohabatti
    NEW MICROBES AND NEW INFECTIONS, 2020, 34
  • [40] Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use
    Lamikanra, Adebayo
    Crowe, Jennifer L.
    Lijek, Rebeccah S.
    Odetoyin, Babatunde W.
    Wain, John
    Aboderin, A. Oladipo
    Okeke, Iruka N.
    BMC INFECTIOUS DISEASES, 2011, 11